Dennis J. Carlo
2018
In 2018, Dennis J. Carlo earned a total compensation of $1.5M as President and Chief Executive Officer at Adamis Pharmaceuticals, a 41% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $343,035 |
|---|---|
| Option Awards | $261,741 |
| Salary | $635,250 |
| Stock Awards | $236,212 |
| Other | $28,496 |
| Total | $1,504,734 |
Carlo received $635.3K in salary, accounting for 42% of the total pay in 2018.
Carlo also received $343K in non-equity incentive plan, $261.7K in option awards, $236.2K in stock awards and $28.5K in other compensation.
Rankings
In 2018, Dennis J. Carlo's compensation ranked 7,139th out of 14,244 executives tracked by ExecPay. In other words, Carlo earned more than 49.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,139 out of 14,244 | 50th |
Division Manufacturing | 2,751 out of 5,759 | 52nd |
Major group Chemicals And Allied Products | 1,037 out of 2,122 | 51st |
Industry group Drugs | 876 out of 1,811 | 52nd |
Industry Pharmaceutical Preparations | 684 out of 1,385 | 51st |
Source: SEC filing on June 25, 2019.
Carlo's colleagues
We found three more compensation records of executives who worked with Dennis J. Carlo at Adamis Pharmaceuticals in 2018.